@article{bb1078fa8b6a41f78f564b1a98e2470f,
title = "Molecular subtypes of upper tract urothelial cancer: Setting the stage for precision therapy",
abstract = "A comprehensive genomic characterization of a large, high-quality cohort of upper tract urothelial carcinomas (UTUCs) in this issue of Cancer Cell reveals that UTUCs can be divided into five DNA-based molecular subtypes. Feasibility data establish that molecular subtyping can be performed non-invasively by sequencing tumor DNA in urine.",
author = "McConkey, {David J.} and Nirmish Singla and Phillip Pierorazio and Kara Lombardo and Andres Matoso and Jean Hoffman-Censits",
note = "Funding Information: The Johns Hopkins UTUC Program recognizes the generous support of Pam and Jim Harris. David McConkey: Janssen, H3 Biomedicine (paid consulting); Astra-Zeneca (research support). Jean Hoffman-Censits: Seattle Genetics, Astra-Zeneca, Genentech, Foundation Medicine (paid consulting); Foundation Medicine (non-financial research support). Philip Pierorazio: Urogen Pharmaceuticals (paid consulting, scientific advisory board, site PI). Andres Matoso: Caris Diagnostics (paid consulting); PATHAI (partner/contractor). Nirmish Singla and Kara Lombardo declare no competing interests. Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",
year = "2021",
month = jun,
day = "14",
doi = "10.1016/j.ccell.2021.05.004",
language = "English (US)",
volume = "39",
pages = "745--747",
journal = "Cancer cell",
issn = "1535-6108",
publisher = "Cell Press",
number = "6",
}